Medicine
Isoflurane, (Volatile for Inhalation) 100 mL/100 mL inhalation solution
Isoflurane, (Volatile for Inhalation) 100 mL/100 mL inhalation solution is a prescription medicine containing Isoflurane for inhalation use, marketed by Mullan Pharmaceutical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 15°-30°C (59°-86°F).
Key facts
- Active ingredient (INN)
- Isoflurane
- Brand
- Isoflurane, (Volatile for Inhalation)
- Strength
- 100 mL/100 mL
- Dosage form
- Inhalation solution
- Route
- Inhalation
- Packs
- 6 bottles
- Marketing authorisation holder
- Mullan Pharmaceutical
- Manufacturer
- Mullan Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 15°-30°C (59°-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01AB06 Isoflurane
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2026
- Identifiers
- RxCUI 542347DailyMed set ID 525a2467-548d-4b10-b181-91b90e99ae1bNDC 83301-0071, 83301-0072Application ANDA216527
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 bottle, glass in 1 case / 100 mL in 1 bottle, glass | 83301-0071-2 | Mullan Pharmaceutical | 1 April 2026 |
| 6 bottle, glass in 1 case / 250 mL in 1 bottle, glass | 83301-0072-2 | Mullan Pharmaceutical | 1 April 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 December 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Isoflurane
Clinical summary
Isoflurane is a general anesthetic indicated for induction and maintenance of general anesthesia. It is available as inhalation solution and inhalant. MedsAcross supplies Isoflurane for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IsofluraneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FORANE prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Isoflurane, (Volatile for Inhalation) 100 mL/100 mL inhalation solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.